BioMarin Pharmaceutical, Inc. (BMRN)
53.74
+0.44
(+0.83%)
USD |
NASDAQ |
Dec 09, 16:00
53.76
+0.02
(+0.03%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Liabilities (Quarterly): 1.558B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Align Technology, Inc. | 2.276B |
| Biogen, Inc. | 11.00B |
| Gilead Sciences, Inc. | 37.08B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Moderna, Inc. | 2.805B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.615B |
| Shareholders Equity (Quarterly) | 6.057B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |